Breast Implant Patient Follow-Up Data Collection Crucial – FDA Guidance

Breast implant manufacturers should offer incentives in order to encourage patient cooperation with post-implant study data collection efforts, FDA advises in a final guidance document

More from Archive

More from Medtech Insight